All April long we've been marking National Donate Life month by partnering with the Gift of Life organization and sharing ...

There are currently no proven therapies that reduce cisplatin-induced acute kidney injury (AKI) in patients with cancer.

Post hoc results support the initiation of SGLT2 inhibitors in patients with diabetic nephropathy regardless of iron deficiency. Canagliflozin treatment may improve iron markers and hemoglobin levels ...

A common diabetes drug can reduce the pain of people with knee osteoarthritis and overweight or obesity, possibly delaying ...

Dr. Matthew Galsky highlights the impact of Imfinzi’s adjuvant approval for patients with muscle-invasive bladder cancer ...